Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
American Journal of Clinical Pathology|January 20, 2022
It Takes a Village: Providing International Pediatric Pathology Services in a Resource-Limited SettingAmanda M Hopp, Julie E Tetzlaff, Kyle Kopidlansky, et al.Pediatric Surgery International|March 14, 2021
COVID-19 pre-procedural testing strategy and early outcomes at a large tertiary care children's hospitalChristina M Bence, Jason A Jarzembowski, Lukas Belter, et al.Science (New York, N.Y.)|June 27, 2009
DICER1 mutations in familial pleuropulmonary blastomaD Ashley Hill, Jennifer Ivanovich, John R Priest, et al.Pediatric Blood & Cancer|May 24, 2021
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group studyBrian D Weiss, Gregory Yanik, Arlene Naranjo, et al.Cancer Discovery|December 18, 2021
A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular EraStefan M Pfister, Miguel Reyes-Múgica, John K C Chan, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2020
Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variationKris Ann P Schultz, Alexander Nelson, Anne K Harris, et al.Pediatric Blood & Cancer|June 30, 2012
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology CommitteeRie Suganuma, Larry L Wang, Hideki Sano, et al.Transplantation and Cellular Therapy|April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.Neuro-Oncology Advances|July 21, 2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testingKristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.Pageof 4